|
S. Todd Lynch, CPA, Chief Financial Officer, is a certified public accountant with 20 years of executive and financial experience with life science companies and public accounting. Prior to joining Metabolon, Mr. Lynch was vice president, global finance for the clinical division of Inveresk, a contract research organization and subsidiary of Charles River Laboratories. Mr. Lynch also served in various financial roles for GlaxoSmithKline and gained seven years of public accounting experience with Coopers & Lybrand specializing in healthcare and manufacturing. | 